KR830007074A - 중추 벤조디아제핀 수용체에 벤조디아제핀의 결합을 증진시키기 위한 조성물 - Google Patents

중추 벤조디아제핀 수용체에 벤조디아제핀의 결합을 증진시키기 위한 조성물 Download PDF

Info

Publication number
KR830007074A
KR830007074A KR1019810003920A KR810003920A KR830007074A KR 830007074 A KR830007074 A KR 830007074A KR 1019810003920 A KR1019810003920 A KR 1019810003920A KR 810003920 A KR810003920 A KR 810003920A KR 830007074 A KR830007074 A KR 830007074A
Authority
KR
South Korea
Prior art keywords
group
benzodiazepine
general formula
chloro
hydrogen atom
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
KR1019810003920A
Other languages
English (en)
Korean (ko)
Inventor
케네드 코에 빌리
Original Assignee
윌리암 데이비스헌
화이자 인코포레이티드
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 윌리암 데이비스헌, 화이자 인코포레이티드 filed Critical 윌리암 데이비스헌
Publication of KR830007074A publication Critical patent/KR830007074A/ko
Abandoned legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Anesthesiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
KR1019810003920A 1980-10-17 1981-10-16 중추 벤조디아제핀 수용체에 벤조디아제핀의 결합을 증진시키기 위한 조성물 Abandoned KR830007074A (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US197872 1980-10-17
US06/197,872 US4320124A (en) 1980-10-17 1980-10-17 Composition for enhancing binding of a benzodiazepine to central benzodiazepine receptors and use thereof

Publications (1)

Publication Number Publication Date
KR830007074A true KR830007074A (ko) 1983-10-14

Family

ID=22731077

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019810003920A Abandoned KR830007074A (ko) 1980-10-17 1981-10-16 중추 벤조디아제핀 수용체에 벤조디아제핀의 결합을 증진시키기 위한 조성물

Country Status (10)

Country Link
US (1) US4320124A (enExample)
EP (1) EP0050487B1 (enExample)
JP (1) JPS5795912A (enExample)
KR (1) KR830007074A (enExample)
AU (1) AU529307B2 (enExample)
DE (1) DE3166349D1 (enExample)
GR (1) GR75097B (enExample)
IL (1) IL64062A0 (enExample)
NZ (1) NZ198657A (enExample)
PT (1) PT73746B (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4406888A (en) * 1981-01-09 1983-09-27 Pfizer Inc. Aqueous micellar solutions of levonantradol and N-methyllevonantradol and lyophilic forms thereof for reconstitution
US6031098A (en) * 1997-08-11 2000-02-29 California Institute Of Technology Detection and treatment of duplex polynucleotide damage
US6617321B2 (en) * 1997-09-30 2003-09-09 Eli Lilly And Company 2-methyl-thieno-benzodiazepine formulation
US20030199496A1 (en) * 2002-04-22 2003-10-23 Simon David Lew Pharmaceutical compositions containing alpha3beta4 nicotinic receptor antagonists and methods of their use
WO2006060736A2 (en) * 2004-12-03 2006-06-08 The Children's Hospital Of Philadelphia A composition and use thereof in enhancing a therapeutic effect of an antiepileptic drug
SI1838716T1 (sl) * 2005-01-05 2011-10-28 Lilly Co Eli Olanzapin pamoat dihidrat

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3862986A (en) * 1966-07-01 1975-01-28 Hoffmann La Roche 1-Hydroxymethyl-amino-2-alkyl-or allyl-2-(3{40 -methoxy-phenyl)-chclohexanes
BE854655A (fr) * 1976-05-17 1977-11-16 Pfizer 9-hydroxyhexahydrobenzo (c) quinoleines et intermediaires de synthese
US4206225A (en) * 1978-09-22 1980-06-03 Pfizer Inc. 2,10-Disubstituted dibenzo[b,d]pyrans and benzo[c]quinolines
US4228169A (en) * 1979-06-26 1980-10-14 Pfizer Inc. 1,9-Dihydroxyoctahydrobenzo[c]quinolines and 1-hydroxyhexahydrobenzo[c]quinoline-9(8H)-ones as antiemetic agents

Also Published As

Publication number Publication date
GR75097B (enExample) 1984-07-13
DE3166349D1 (en) 1984-10-31
AU529307B2 (en) 1983-06-02
JPS5795912A (en) 1982-06-15
PT73746A (en) 1981-10-01
AU7651781A (en) 1982-04-22
EP0050487A1 (en) 1982-04-28
NZ198657A (en) 1985-05-31
IL64062A0 (en) 1982-01-31
EP0050487B1 (en) 1984-09-26
PT73746B (en) 1983-11-08
US4320124A (en) 1982-03-16

Similar Documents

Publication Publication Date Title
TR200202287T2 (tr) Sübstitüe edilmiş N6 heterosiklik adenosin türevleri
KR960705810A (ko) 퀴나졸린 유도체(quinazoline derivatives)
ATE4709T1 (de) Substituierte imidazole, ihre herstellung und sie enthaltende pharmazeutische zusammensetzungen.
KR830007074A (ko) 중추 벤조디아제핀 수용체에 벤조디아제핀의 결합을 증진시키기 위한 조성물
KR880001212A (ko) 치환 히드라존을 사용하여 식물 선충류를 박멸 시키는 방법
ATE247959T1 (de) Nicht peptidische g-csf mimetika
KR970707108A (ko) 항염증제로 유용한, 복소환부를 갖는 디-t-부틸페놀 화합물(DI-TERT-BUTYLPHENOL COMPOUNDS WITH HETEROCYCLIC MOIETY, USEFUL AS ANTI-INFLAMMATORY AGENTS)
NZ188656A (en) Preparation of 7-chloro-5-(2-chlorophenyl)-1,2-dihydro-3h-1,4-benzodiazepin-2-one
IE842332L (en) Trioxopyrimidines
AR004474A1 (es) Compuestos de 10-aminoalifatil-dibenz [b,f]oxepinas antineurodegenerativamente activas, utiles para el tratamiento de estados neurodegenerativos y composiciones farmaceuticas que los contienen
ATE1624T1 (de) 6-arylpyridazin-3-one, diese enthaltende pharmazeutische zubereitungen und verfahren zu ihrer herstellung.
ATE13880T1 (de) N-2-hydroxypropyl-piperidine und verfahren zu ihrer herstellung.
US5198436A (en) Intraoral dosing method of administering trifluorobenzodiazepines
ATE15802T1 (de) 2-acylaminomethyl-1,4-benzodiazepin-verbindunge sowie verfahren und zwischenprodukte zu ihrer herstellung und diese verbindungen enthaltende arzneimittel.
KR910002858A (ko) 4H-인돌로[1,2-d][1,2,4]트리아졸로[4,3-a][1,4]벤조디아제핀, 이의 제조방법 및 약제로서의 용도
EP0167920A3 (en) Benzodiazepine derivatives and pharmaceutical compositions containing them
US3801569A (en) 7-(1,1-difluoroalkyl)-1,4-benzodiazepines
ATE42291T1 (de) Spiro(indolo(1,7-ab>(1,5>benzodiazepin-2,4'piperidine> und zwischenprodukte, verfahren zu ihrer herstellung und ihre anwendung als arzneimittel.
US3627754A (en) Process for preparing 7-lower alkanoyl benzodiazepines utilizing ceric salts
PH21768A (en) Analgesic pharmaceutical compositions containing 4-phenyl-1,4-benzo diazepine compounds and a method of using same
KR920003976A (ko) 면역억제제로서의 5'-아민 치환 아데노신 동족체
KR920004559A (ko) 1,1-디클로로-1- 플루오로에탄, 염화메틸렌 및 메탄올 기재 세정 조성물
KR900014390A (ko) 아데노신 수용체 선택성 화합물
ATE26116T1 (de) (1,2)-anellierte 1,4-benzodiazepin-verbindungen sowie verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel.
KR950031021A (ko) 양모 조성물

Legal Events

Date Code Title Description
PA0109 Patent application

Patent event code: PA01091R01D

Comment text: Patent Application

Patent event date: 19811016

PG1501 Laying open of application
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 19850701

Patent event code: PE09021S01D

PC1902 Submission of document of abandonment before decision of registration